How a global biopharma company became a leader in ethical AI
Artificial Intelligence (AI) has emerged as a key agent of transformation, creating opportunities for enhanced insight and efficiency in all industries. Biopharma is no exception.
EY teams used the global Responsible AI framework to help a biopharma optimize AI governance, mitigate AI risks and protect stakeholders.
Read more HERE